July has dealt Wall Street a turbulent hand. US stocks have drifted lower this month, hampered by persistent geopolitical risks, rising crude oil prices, and mounting anxiety over rising AI capex.
Health stocks had a strong week, with some big firms seeing drugs approved. Eli Lilly (LLY) reportedly neared an agreement to acquire a psychedelics company.
Every claim UnitedHealth processes, every prior authorization it reviews and every patient interaction it handles now runs through artificial intelligence (AI). The company is turning that internal overhaul into a commercial product line.
Every claim UnitedHealth processes, every prior authorization it reviews and every patient interaction it handles now runs through artificial intelligence (AI). The company is turning that internal overhaul into a commercial product line.
Shares of UnitedHealth Group jumped to their highest level in more than a year Thursday after the health care and insurance giant announced results that handily topped Wall Street expectations.
UnitedHealth Group Inc (NYSE:UNH, XETRA:UNH) shares climbed about 5% in post-market trading after the healthcare company reported second quarter results that beat Wall Street expectations and raised its full-year adjusted earnings outlook. For the quarter ended June 30, UnitedHealth reported adjusted earnings of $6.38 per share, ahead of analysts' expectations of about $4.91 per share.
AMD, Dell, Intel, and Micron shares fall as Wall Street questions how long the AI spending boom can last.